Pendapatan operasional sadurunge ngurangi amortisasi: codiagnostics.com (CODX)

Tandha merek Co-Diagnostics (CODX)

The projected EBITDA level demonstrates operational efficiency dynamics, where 0.00 serves as the base parameter value. Co-Diagnostics, Inc. (CODX) is scaling the deployment of PCR systems through B2B contracts with laboratories to capture market share. Growth is driven by home platforms and tropical disease tests. High liquidity and stable cash flow completely offset financial risks associated with the creation of new products.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Co-Diagnostics, Inc. (CODX) kanggo 23.11.2025 - 11.11.2026

Ringkesan rincian data analitis Co-Diagnostics (CODX)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:CODX, CoDx
Produk seri Co-Diagnostics, Inc.

To minimize long-term capital risks, it is critical to monitor the slowing growth of real cash flow from operating activities, which this operational financial result clearly reflects. Since the success of Co-Diagnostics, Inc. (CODX) depends on the commercialization of developments and product cycles, analyzing the dynamics of profit before non-cash expenses allows for an assessment of business scaling efficiency and helps avoid purchasing the asset at its peak liquidity.

Karo sapa Co-Diagnostics, Inc. saingan

Agilent Corp (A) - Bathi sadurunge bunga, pajak, lan amortisasi|DGX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi illumina.com ILMN|EXAS: Bathi operasional EBITDA|RVTY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA SHC|Bathi operasional sadurunge ngurangi amortisasi quidel.com QDEL|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OPKO Health OPK|CareDx Corp (CDNA) - Bathi sadurunge bunga, pajak, lan amortisasi|MRVI: Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge potongan amortisasi Fulgent (FLGT)|LAB: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi CTKB|OSUR (OraSure) - Bathi operasional EBITDA|Exagen Diagnostics (XGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA MDXH|Bathi operasional EBITDA Lucid Diagnostics, Inc (LUCD)|Bathi operasional EBITDA PRE (Prenetics)|Bathi operasional sadurunge potongan amortisasi Insight Molecular Diagnostics, Inc.|TRIB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PRPH (ProPhase Labs Inc) - Bathi operasional sadurunge amortisasi|Ainos Corp (AIMD) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Heart Test Labs (HSCS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Biomerica, Inc.|Cardio Diagnostics Holdings, Inc. (CDIO) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi ONCO (Onconetix)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi VRAX|Bathi operasional EBITDA BJDX (Bluejay)|Pendapatan operasional sadurunge ngurangi amortisasi Aspira Women's Health Inc (AWH)|Accelerate Diagnostics - Bathi operasional EBITDA|Centogene (CNTG) - Bathi operasional sadurunge ngurangi amortisasi|enzo.com (ENZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|FRES - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi GENE|ME: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA PMD